TJ
Terrance Joseph Coughlin
About Terrance Joseph Coughlin
Data last updated:
Terrance Joseph Coughlin was a Director at Glenmark Generics Limited (2008–2013), Director at Par Formulations Private Limited (2017–2020) and Director at Par Active Technologies Private Limited (2017–2020), and held 1 more directorship. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glenmark Generics Limited U24110MH1994PLC081597 | Director | 26 Mar 2008 | 1994 | Amalgamated | |
 Par Formulations Private Limited U33111TN1982PTC009602 | Director | 02 Mar 2017 | 1982 | ₹1,462 Cr (FY 2025) | Active |
 Par Active Technologies Private Limited U24232TN2013PTC093471 | Director | 02 Mar 2017 | 2013 | ₹103 Cr (FY 2025) | Active |
 Par Biosciences Private Limited U24233TN2012PTC086326 | Director | 02 Mar 2017 | 2012 | ₹3.31 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Terrance Joseph Coughlin
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Terrance Joseph Coughlin
Terrance Joseph Coughlin was first appointed on 26 Mar 2008 as Director at Glenmark Generics Limited. The most recent appointment on record is 02 Mar 2017 at Par Biosciences Private Limited.
Terrance Joseph Coughlin held 4 earlier board appointments: Glenmark Generics Limited (Director, 26 Mar 2008 to 18 Oct 2013); Par Formulations Private Limited (Director, 02 Mar 2017 to 01 Dec 2020); Par Active Technologies Private Limited (Director, 02 Mar 2017 to 01 Dec 2020); Par Biosciences Private Limited (Director, 02 Mar 2017 to 01 Dec 2020).